MARC Record from marc_columbia

LEADER: 02077mam a2200469 a 4500
001 2548494
005 20221012192329.0
008 000310s2000 nyua b 101 0 eng c
010 $a 00029181
020 $a1573312134 (cloth : alk. paper)
020 $a1573312142 (paper : alk. paper)
035 $a(OCoLC)ocm43650743
035 $9AQN2352CU
035 $a(NNC)2548494
035 $a2548494
040 $aNLM$cNLM$dMIA$dNNC
042 $apcc
060 10 $aW1$bAN626YL v. 905 2000
060 10 $aQU 90$bL995 2000
069 0 $a100937963
090 $aQ11$b.N5 v.905
245 00 $aLysophospholipids and eicosanoids in biology and pathophysiology /$cedited by Edward J. Goetzl and Kevin R. Lynch.
260 $aNew York, N.Y. :$bNew York Academy of Sciences,$c2000.
263 $a0003
300 $axiv, 357 pages :$billustrations ;$ccm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAnnals of the New York Academy of Sciences,$x0077-8923 ;$vv. 905
504 $aIncludes bibliographical references and index.
650 0 $aLysophospholipids$vCongresses.
650 0 $aEicosanoids$vCongresses.
650 0 $aCell receptors$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008100246
650 12 $aLysophospholipids$xphysiology.$0https://id.nlm.nih.gov/mesh/D008246Q000502
650 22 $aEicosanoids$xadverse effects.$0https://id.nlm.nih.gov/mesh/D015777Q000009
650 22 $aEicosanoids$xphysiology.$0https://id.nlm.nih.gov/mesh/D015777Q000502
650 22 $aLysophospholipids$xadverse effects.$0https://id.nlm.nih.gov/mesh/D008246Q000009
650 22 $aReceptors, Cell Surface$xphysiology.$0https://id.nlm.nih.gov/mesh/D011956Q000502
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aGoetzl, Edward J.$0http://id.loc.gov/authorities/names/n82076701
700 1 $aLynch, Kevin R.$0http://id.loc.gov/authorities/names/n97069922
830 0 $aAnnals of the New York Academy of Sciences ;$vv. 905.$0http://id.loc.gov/authorities/names/n42032359
852 00 $boff,sci$hQ11$i.N42 v.905